BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 40410)

  • 1. On the effect of sulphasalazine on the prostaglandin system and the defective prostaglandin inactivation observed in experimental ulcerative colitis.
    Hoult JR; Moore PK; Marcus AJ; Watt J
    Agents Actions Suppl; 1979; (4):232-44. PubMed ID: 40410
    [No Abstract]   [Full Text] [Related]  

  • 2. Ulcerative colitis: effect of sulphasalazine, its metabolites and indomethacin on the ability of human colonic mucosa to metabolize prostaglandins in vitro.
    Hillier K; Mason PJ; Pacheco S; Smith CL
    Br J Pharmacol; 1982 May; 76(1):157-61. PubMed ID: 6123357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostaglandins and mechanism of action of sulphasalazine in ulcerative colitis.
    Moore PK; Hoult JR; Laurie A
    Lancet; 1978 Jul; 2(8080):98-9. PubMed ID: 78320
    [No Abstract]   [Full Text] [Related]  

  • 4. Studies of prostaglandins and sulphasalazine in ulcerative colitis.
    Gould SR; Brash AR; Conolly ME; Lennard-Jones JE
    Prostaglandins Med; 1981 Feb; 6(2):165-82. PubMed ID: 6113614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sulphasalazine inhibits the pulmonary inactivation of prostaglandins in the rat in vivo [proceedings].
    Hoult JR; Moore PK; Ramcharan E
    Br J Pharmacol; 1979 May; 66(1):101P-102P. PubMed ID: 36949
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of sulphasalazine on prostaglandin inactivation and synthesis in isolated lungs of guinea pig, rat and man.
    Bakhle YS
    Eur J Pharmacol; 1980 Dec; 68(4):493-6. PubMed ID: 6110554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of sulphasalazine and disodium azodisalicylate on colonic PGE2 concentrations determined by equilibrium in vivo dialysis of faeces in patients with ulcerative colitis and healthy controls.
    Lauritsen K; Hansen J; Bytzer P; Bukhave K; Rask-Madsen J
    Gut; 1984 Nov; 25(11):1271-8. PubMed ID: 6149981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced thromboxane A2 and prostacyclin production by cultured rectal mucosa in ulcerative colitis and its inhibition by steroids and sulfasalazine.
    Ligumsky M; Karmeli F; Sharon P; Zor U; Cohen F; Rachmilewitz D
    Gastroenterology; 1981 Sep; 81(3):444-9. PubMed ID: 6114012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The ubiquitous prostaglandins and their role in ulcerative colitis.
    Kimberg DV
    Gastroenterology; 1978 Oct; 75(4):748-50. PubMed ID: 30671
    [No Abstract]   [Full Text] [Related]  

  • 10. Prostaglandin catabolism and ulcerative colitis: effect of sulphasalazine, 5-aminosalicylic acid and other drugs.
    Pacheco S; Hillier K; Smith CL
    Braz J Med Biol Res; 1990; 23(12):1323-34. PubMed ID: 1983789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostaglandins and sulphasalazine.
    Smith PR; Dawson DJ; Swan CH
    Lancet; 1978 Jul; 2(8083):260. PubMed ID: 79051
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of Manuka honey and sulfasalazine in combination to promote antioxidant defense system in experimentally induced ulcerative colitis model in rats.
    Medhi B; Prakash A; Avti PK; Saikia UN; Pandhi P; Khanduja KL
    Indian J Exp Biol; 2008 Aug; 46(8):583-90. PubMed ID: 18814487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of sulphasalazine and its metabolites on prostaglandin synthesis, inactivation and actions on smooth muscle.
    Hoult JR; Moore PK
    Br J Pharmacol; 1980 Apr; 68(4):719-30. PubMed ID: 6103724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostaglandins and ulcerative colitis, a warning.
    Gerber JG
    Gastroenterology; 1979 Mar; 76(3):658. PubMed ID: 34557
    [No Abstract]   [Full Text] [Related]  

  • 15. Sulphasalazine is a potent inhibitor of prostaglandin 15-hydroxydehydrogenase: possible basis for therapeutic action in ulcerative colitis.
    Hoult JR; Moore PK
    Br J Pharmacol; 1978 Sep; 64(1):6-8. PubMed ID: 29685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of sulphasalazine withdrawal on rectal mucosal function and prostaglandin E2 release in inactive ulcerative colitis.
    Rampton DS; Sladen GE
    Scand J Gastroenterol; 1981; 16(1):157-9. PubMed ID: 6112788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostaglandins and ulcerative colitis.
    Rampton DS; Hawkey CJ
    Gut; 1984 Dec; 25(12):1399-413. PubMed ID: 6150882
    [No Abstract]   [Full Text] [Related]  

  • 18. Characteristics of immune-complex-induced chronic experimental colitis in rats with a therapeutic effect of sulphasalazine.
    Axelsson LG; Ahlstedt S
    Scand J Gastroenterol; 1990 Mar; 25(3):203-9. PubMed ID: 1969677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammatory bowel disease: the in vitro effect of sulphasalazine and other agents on prostaglandin synthesis by human rectal mucosa.
    Pacheco S; Hillier K; Smith CL
    Braz J Med Biol Res; 1987; 20(2):221-30. PubMed ID: 2891390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of sulphasalazine on pulmonary inactivation of prostaglandin F2 alpha in the pig.
    Hellewell PG; Pearson JD
    Br J Pharmacol; 1982 Jun; 76(2):319-26. PubMed ID: 6178459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.